Subtype identification and risk model establishment to predict prognosis and drug therapy response in colon cancer based on efferocytosis-related genes

Read full text Summarise with VIRAT
Authors: Xiayan Sun, Fei Chen
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Efferocytosis can promote tumor immune evasion. This study identified three molecular subtypes and constructed a six-gene prognostic model for colon cancer based on efferocytosis-related genes and data from The Cancer Genome Atlas (TCGA). Patients in the high-risk group defined by this model showed higher levels of immunosuppressive cell infiltration and increased mutation rates, exhibiting poorer responses to immunotherapy. The model gene LHX3 was highly expressed in colon cancer, promoting malignant cellular phenotypes and influencing efferocytosis. Overall, the efferocytosis-based risk model constructed in this study may provide insights for prognostic evaluation and therapeutic strategies in colon cancer.

Fields of Study & Subjects

Phagocytosis and Immune Regulation Ferroptosis and cancer prognosis Colorectal Cancer Treatments and Studies

Publication details

Journal / source
Figshare
Publication date
21 March 2026
Language
EN
Document type
Dataset